{"id":2806,"date":"2025-10-14T09:18:24","date_gmt":"2025-10-14T13:18:24","guid":{"rendered":"https:\/\/medicamentquebec.ca\/?p=2806"},"modified":"2025-11-12T12:45:26","modified_gmt":"2025-11-12T17:45:26","slug":"medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales","status":"publish","type":"post","link":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/","title":{"rendered":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales"},"content":{"rendered":"<p><strong>14 octobre 2025 &#8211; Nouvelles de M\u00e9dicament Qu\u00e9bec<\/strong><\/p>\n<p><!--more--><\/p>\n<p><strong>Montr\u00e9al, QC, 14 octobre 2025<\/strong> \u2014 M\u00e9dicament Qu\u00e9bec est fi\u00e8re d\u2019annoncer un investissement de 2,2\u00a0millions de dollars pour soutenir deux nouvelles activit\u00e9s structurantes dans le cadre de son programme Innovations en technologies vaccinales, financ\u00e9 par le gouvernement du Qu\u00e9bec. Ces activit\u00e9s collaboratives entre le milieu acad\u00e9mique et l\u2019industrie, men\u00e9es par des chercheurs principaux de renom, visent \u00e0 d\u00e9velopper des plateformes novatrices et p\u00e9rennes qui contribueront \u00e0 renforcer l\u2019\u00e9cosyst\u00e8me qu\u00e9b\u00e9cois des vaccins.<\/p>\n<p>Ces activit\u00e9s se distinguent par un accompagnement soutenu de M\u00e9dicament Qu\u00e9bec. Apr\u00e8s une premi\u00e8re \u00e9valuation, elles ont \u00e9t\u00e9 retravaill\u00e9es en collaboration avec les chercheurs et des membres du comit\u00e9 d\u2019\u00e9valuation dans le cadre d\u2019un processus it\u00e9ratif afin d\u2019int\u00e9grer les recommandations, renforcer leur pertinence industrielle et garantir la mise en place de plateformes mutualisables, adaptables \u00e0 diff\u00e9rents domaines d\u2019application. Ce processus a permis de consolider des activit\u00e9s plus robustes gr\u00e2ce au soutien d\u2019un r\u00e9seau mobilis\u00e9 vers leur r\u00e9ussite\u00a0: une valeur ajout\u00e9e qui illustre la diff\u00e9rence M\u00e9dicament Qu\u00e9bec.<\/p>\n<p>Les activit\u00e9s financ\u00e9es sont:<\/p>\n<ul>\n<li><strong>Pr Denis Leclerc, professeur titulaire, d\u00e9partement de microbiologie-infectiologie et d\u2019immunologie, Universit\u00e9 Laval et Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval<\/strong><br \/>\n<strong><em>VaxSynergy \u2014 Affranchir l\u2019innovation dans le d\u00e9veloppement de vaccins gr\u00e2ce \u00e0 un \u00e9cosyst\u00e8me collaboratif<\/em><\/strong><strong> &#8211; <\/strong>Financement de 1,5\u00a0M$<br \/>\nCette activit\u00e9 mettra en place une plateforme int\u00e9gr\u00e9e regroupant plusieurs expertises acad\u00e9miques et industrielles afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement de vaccins sous-unitaires et d\u2019adjuvants novateurs, de la d\u00e9couverte jusqu\u2019aux applications cliniques.<\/li>\n<li><strong>Pre Maryam Tabrizian, professeure titulaire, d\u00e9partement de g\u00e9nie biom\u00e9dical, Universit\u00e9 McGill<\/strong><br \/>\n<em>Mise en place d\u2019une plateforme pour innover dans des vaccins th\u00e9rapeutiques \u00e0 base de nanoparticules immunomodulatrices d\u00e9riv\u00e9es de lipides bact\u00e9riens contre le cancer<\/em><strong> &#8211; <\/strong>Financement de 0,8M$<br \/>\nCette activit\u00e9 vise \u00e0 cr\u00e9er une plateforme technologique de nouvelle g\u00e9n\u00e9ration exploitant des nanoparticules lipidiques hybrides pour d\u00e9velopper des vaccins th\u00e9rapeutiques \u00e0 base d\u2019ARN contre le cancer m\u00e9tastatique.<\/li>\n<\/ul>\n<p>\u00ab\u2009<em>Nous sommes fiers de voir \u00e9merger un total de six activit\u00e9s structurantes porteuses en technologies vaccinales, qui viennent compl\u00e9ter un portefeuille de 19\u00a0activit\u00e9s soutenues par M\u00e9dicament Qu\u00e9bec, tant en petites mol\u00e9cules, en ARN, qu\u2019en vaccins. Ensemble, ces activit\u00e9s contribuent \u00e0 b\u00e2tir un \u00e9cosyst\u00e8me plus fort, connect\u00e9 et structur\u00e9 pour le d\u00e9veloppement du m\u00e9dicament au Qu\u00e9bec<\/em>\u2009\u00bb, souligne Arianne Trudeau, directrice ex\u00e9cutive, M\u00e9dicament Qu\u00e9bec.<\/p>\n<p>\u00ab\u00a0<em>C\u2019est avec beaucoup de fiert\u00e9 que le gouvernement du Qu\u00e9bec appuie le programme Innovations en technologies vaccinales de M\u00e9dicament\u00a0Qu\u00e9bec et qu\u2019il constate, une fois de plus, les retomb\u00e9es positives qu\u2019il g\u00e9n\u00e8re. Nous croyons fermement que la collaboration au sein de l\u2019\u00e9cosyst\u00e8me du secteur des sciences de la vie est la cl\u00e9 pour amener le Qu\u00e9bec \u00e0 devenir toujours plus autonome et innovant dans le d\u00e9veloppement de m\u00e9dicaments<\/em>\u00a0\u00bb, soutient Christine\u00a0Fr\u00e9chette, ministre de l\u2019\u00c9conomie, de l\u2019Innovation et de l\u2019\u00c9nergie.<\/p>\n<p>Pour en savoir plus sur les activit\u00e9s financ\u00e9es, <a href=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/\">cliquez ici<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\">-30-<\/p>\n<p><strong>Pour plus d\u2019information<\/strong><\/p>\n<p>Arianne Trudeau<br \/>\nDirectrice ex\u00e9cutive<br \/>\nM\u00e9dicament Qu\u00e9bec<br \/>\narianne.trudeau@umontreal.ca<\/p>\n<p><strong>\u00c0 propos<\/strong><\/p>\n<p>M\u00e9dicament Qu\u00e9bec une initiative financ\u00e9e par le gouvernement du Qu\u00e9bec, rassemble des \u00e9tablissements de recherche et d\u2019enseignement ainsi que des entreprises autour d\u2019un projet commun. Elle vise \u00e0 accroitre l\u2019autonomie et le dynamisme du Qu\u00e9bec et du Canada en mati\u00e8re de bioinnovation et de biofabrication. M\u00e9dicament Qu\u00e9bec soutient des activit\u00e9s acad\u00e9miques structurantes et collaboratives afin de renforcer les cha\u00eenes d\u2019approvisionnement locales en mati\u00e8re de m\u00e9dicaments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>14 octobre 2025 &#8211; Nouvelles de M\u00e9dicament Qu\u00e9bec<\/p>\n","protected":false},"author":7,"featured_media":2823,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[85,1],"tags":[],"class_list":["post-2806","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"og:description\" content=\"14 octobre 2025 &#8211; Nouvelles de M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/\" \/>\n<meta property=\"og:site_name\" content=\"M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T13:18:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-12T17:45:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"St\u00e9phanie Bilodeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"St\u00e9phanie Bilodeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/\"},\"author\":{\"name\":\"St\u00e9phanie Bilodeau\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\"},\"headline\":\"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales\",\"datePublished\":\"2025-10-14T13:18:24+00:00\",\"dateModified\":\"2025-11-12T17:45:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-vaccins-FR.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/\",\"name\":\"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-vaccins-FR.png\",\"datePublished\":\"2025-10-14T13:18:24+00:00\",\"dateModified\":\"2025-11-12T17:45:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#primaryimage\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-vaccins-FR.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-vaccins-FR.png\",\"width\":1200,\"height\":628,\"caption\":\"Financement Technologies vaccinales Tabrizian Leclerc\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/14\\\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/medicamentquebec.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicamentquebec.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"width\":494,\"height\":266,\"caption\":\"M\u00e9dicament Qu\u00e9bec\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\",\"name\":\"St\u00e9phanie Bilodeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"caption\":\"St\u00e9phanie Bilodeau\"},\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/author\\\/bilodeaus\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/","og_locale":"fr_FR","og_type":"article","og_title":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec","og_description":"14 octobre 2025 &#8211; Nouvelles de M\u00e9dicament Qu\u00e9bec","og_url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/","og_site_name":"M\u00e9dicament Qu\u00e9bec","article_published_time":"2025-10-14T13:18:24+00:00","article_modified_time":"2025-11-12T17:45:26+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png","type":"image\/png"}],"author":"St\u00e9phanie Bilodeau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"St\u00e9phanie Bilodeau","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#article","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/"},"author":{"name":"St\u00e9phanie Bilodeau","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f"},"headline":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales","datePublished":"2025-10-14T13:18:24+00:00","dateModified":"2025-11-12T17:45:26+00:00","mainEntityOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/"},"wordCount":671,"publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png","articleSection":["Actualit\u00e9s","Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/","url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/","name":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales - M\u00e9dicament Qu\u00e9bec","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#primaryimage"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png","datePublished":"2025-10-14T13:18:24+00:00","dateModified":"2025-11-12T17:45:26+00:00","breadcrumb":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#primaryimage","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-vaccins-FR.png","width":1200,"height":628,"caption":"Financement Technologies vaccinales Tabrizian Leclerc"},{"@type":"BreadcrumbList","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/14\/medicament-quebec-finance-deux-activites-structurantes-additionnelles-en-technologies-vaccinales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/medicamentquebec.ca\/"},{"@type":"ListItem","position":2,"name":"M\u00e9dicament Qu\u00e9bec finance deux activit\u00e9s structurantes additionnelles en technologies vaccinales"}]},{"@type":"WebSite","@id":"https:\/\/medicamentquebec.ca\/#website","url":"https:\/\/medicamentquebec.ca\/","name":"M\u00e9dicament Qu\u00e9bec","description":"","publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicamentquebec.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/medicamentquebec.ca\/#organization","name":"M\u00e9dicament Qu\u00e9bec","url":"https:\/\/medicamentquebec.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","width":494,"height":266,"caption":"M\u00e9dicament Qu\u00e9bec"},"image":{"@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f","name":"St\u00e9phanie Bilodeau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","caption":"St\u00e9phanie Bilodeau"},"url":"https:\/\/medicamentquebec.ca\/index.php\/author\/bilodeaus\/"}]}},"_links":{"self":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/comments?post=2806"}],"version-history":[{"count":4,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2806\/revisions"}],"predecessor-version":[{"id":3015,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2806\/revisions\/3015"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media\/2823"}],"wp:attachment":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media?parent=2806"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/categories?post=2806"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/tags?post=2806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}